Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection.
- Citation data:
The Journal of antimicrobial chemotherapy, ISSN: 1460-2091, Vol: 72, Issue: 2, Page: 522-528
- Publication Year:
- Pharmacology, Toxicology and Pharmaceutics; Medicine
- Most Recent Tweet View All Tweets
Recipients of faecal microbiota transplantation (FMT) in treatment of recurrent Clostridium difficile infection (RCDI) remain at markedly increased risk of re-infection with C. difficile with new antibiotic provocations. Urinary tract infections (UTIs) are common indications for antibiotics in these patients, often resulting in C. difficile re-infection.